These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 2133586)
1. [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole]. Ferreira Hde O Rev Soc Bras Med Trop; 1990; 23(4):209-11. PubMed ID: 2133586 [TBL] [Abstract][Full Text] [Related]
2. [Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox]. Andrade SG; Magalhães JB; Pontes AL Rev Soc Bras Med Trop; 1989; 22(3):113-8. PubMed ID: 2518608 [TBL] [Abstract][Full Text] [Related]
3. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245 [TBL] [Abstract][Full Text] [Related]
4. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678 [TBL] [Abstract][Full Text] [Related]
5. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]. Coura JR; de Abreu LL; Willcox HP; Petana W Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337 [TBL] [Abstract][Full Text] [Related]
6. [Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina]. Streiger ML; del Barco ML; Fabbro DL; Arias ED; Amicone NA Rev Soc Bras Med Trop; 2004; 37(5):365-75. PubMed ID: 15361952 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase]. Silveira CA; Castillo E; Castro C Rev Soc Bras Med Trop; 2000; 33(2):191-6. PubMed ID: 10881133 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Andrade SG; Magalhães JB; Pontes AL Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634 [TBL] [Abstract][Full Text] [Related]
9. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy]. Gallerano RR; Sosa RR Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232 [TBL] [Abstract][Full Text] [Related]
10. Etiological drug treatment of human infection by Trypanosoma cruzi. Levi GC; Lobo IM; Kallás EG; Amato Neto V Rev Inst Med Trop Sao Paulo; 1996; 38(1):35-8. PubMed ID: 8762637 [TBL] [Abstract][Full Text] [Related]
11. Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia. Bianchi F; Cucunubá Z; Guhl F; González NL; Freilij H; Nicholls RS; Ramírez JD; Montilla M; Flórez AC; Rosas F; Saavedra V; Silva N PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003465. PubMed ID: 25723465 [TBL] [Abstract][Full Text] [Related]
12. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients. Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. Solari A; Ortíz S; Soto A; Arancibia C; Campillay R; Contreras M; Salinas P; Rojas A; Schenone H J Antimicrob Chemother; 2001 Oct; 48(4):515-9. PubMed ID: 11581230 [TBL] [Abstract][Full Text] [Related]
14. The effect of benznidazole dose among the efficacy outcome in the murine animal model. A quantitative integration of the literature. Molina I; Perin L; Aviles AS; de Abreu Vieira PM; da Silva Fonseca K; Cunha LM; Carneiro CM Acta Trop; 2020 Jan; 201():105218. PubMed ID: 31610148 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid]. Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi GG; Rassi Junior A Rev Soc Bras Med Trop; 2002; 35(6):547-50. PubMed ID: 12612733 [TBL] [Abstract][Full Text] [Related]
16. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review. Arrúa EC; Seremeta KP; Bedogni GR; Okulik NB; Salomon CJ Acta Trop; 2019 Oct; 198():105080. PubMed ID: 31299283 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Sosa Estani S; Segura EL Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():363-5. PubMed ID: 10677756 [No Abstract] [Full Text] [Related]
19. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs]. Levy AM; Pereira VL; Boainain E Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793 [No Abstract] [Full Text] [Related]
20. [Changes in parasitemia evaluated using the modified Strout method in patients with acute Chagas disease under treatment]. Castro C; Emanuel A Rev Soc Bras Med Trop; 1988; 21(4):177-80. PubMed ID: 3152133 [No Abstract] [Full Text] [Related] [Next] [New Search]